Biologics Safety Testing Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Biologics Safety Testing Market is expected to witness a CAGR of 12% during the forecast period 2022-2028.

Biologic safety testing is performed on drugs, vaccines, therapeutics, stem or tissue cells, and other blood-derived products. Testing ensures that products are free of contamination. The growth of the biopharmaceutical product pipeline will accelerate the market growth of biopharmaceutical safety testing. The current COVID-19 pandemic is further increasing vaccine testing and attempts to develop a coronavirus vaccine. Thus, government initiatives for the same will and vaccine production drive the market. Biologics are advanced drugs used to treat cancer, cardiovascular, rheumatoid arthritis and other diseases. Biologics contain large molecules such as monoclonal antibodies and recombinant proteins, and the safety of these molecules ensures patient safety as they are used in the treatment of the above-mentioned diseases.

Market Segments

By Application

• Vaccine Development
• Blood Products Testing
• Cellular & Gene Therapy
• Tissue and Tissue-Related Products Testing
• Stem Cell Research

By Test Type

• Endotoxin Tests
• Sterility Tests
• Cell Line Authentication and Characterization Tests
• Bioburden Tests
• Cell Line Authentication
• Residual Host Contaminant Detection Tests
• Adventitious Agent Detection Tests

Key Players

• Charles River Laboratories International, Inc.
• Eurofins Scientific Se
• SGS S.A.
• Thermo Fisher Scientific Inc.
• Genscript
• Biomérieux Sa
• Pace Analytical Services Inc.
• Lonza Group Ltd.
• Toxikon Corporation
• Wuxi Apptec

Scope of the Report

The research study analyzes the global Biologics Safety Testing industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Biologics Safety Testing Market Report

1. What was the Biologics Safety Testing Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Biologics Safety Testing Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Biologics Safety Testing Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.